title: [Neoadjuvant therapy may allow unresectable tumors becoming resectable].
abstract: Should we consider surgery for pancreatic cancer when resectability seems initially uncertain? The answer is no consensual as illustrated by the controversy presented here. This article presents the key arguments in favor surgery.
authors.affiliation: Service de chirurgie hépatobiliaire et transplantation hépatique, Centre hépatobiliaire, Hôpital Paul-Brousse, 12-14, avenue Paul-Vaillant-Couturier, 94800 Villejuif, France. Electronic address: antonio.sacunha@pbr.aphp.fr.
authors.forename: Antonio
authors.initials: A
authors.lastname: Sa Cunha
mesh_terms: D000230:Adenocarcinoma / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D003952:Diagnostic Imaging; D006801:Humans; D020360:Neoadjuvant Therapy; D010190:Pancreatic Neoplasms / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D018579:Patient Selection; D018714:Radiotherapy, Adjuvant
keywords: Cancer du pancréas; Chirurgie; Neoadjuvant treatments; Pancreatic cancer; Surgery; Traitements néo-adjuvants